These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11387305)

  • 21. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
    Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
    Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.
    Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS
    J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study.
    Agarwal R; Teoh S; Short D; Harvey R; Savage PM; Seckl MJ
    Lancet; 2012 Jan; 379(9811):130-5. PubMed ID: 22130490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of hydatidiform mole after primary evacuation.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    Am J Obstet Gynecol; 1983 Mar; 145(5):591-5. PubMed ID: 6829636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases.
    Zalel Y; Dgani R
    Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):67-71. PubMed ID: 9031962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
    Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regression of hCG in various types of molar pregnancies--clinical course and prognosis].
    Rob L; Robová H; Pluta M; Kulovaný E; Hrehorcák M; Chmel R; Schlegerová D; Kodet R; Macek M
    Ceska Gynekol; 2001 Jul; 66(4):230-5. PubMed ID: 11569415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
    Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
    Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit.
    Sebire NJ; Foskett M; Short D; Savage P; Stewart W; Thomson M; Seckl MJ
    BJOG; 2007 Jun; 114(6):760-2. PubMed ID: 17516969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Criteria for initiating chemotherapy in patients after evacuation of hydatidiform mole.
    Matsui H; Iitsuka Y; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
    Tumour Biol; 2003; 24(3):140-6. PubMed ID: 14610317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M; Bagshawe KD
    Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease.
    Murad TM; Longley JV; Lurain JR; Brewer JI
    Int J Gynaecol Obstet; 1990 Aug; 32(4):359-67. PubMed ID: 1977631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial hydatidiform mole with subsequent trophoblastic tumor; a case report.
    Vejerslev LO; Larsen G; Jacobsen M
    Eur J Obstet Gynecol Reprod Biol; 1991 Jun; 40(1):73-7. PubMed ID: 1649776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.